Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
At close: Sep 4, 2026 · 4:00 PM EDT

Incyte (INCY) Enterprise Value (2010 - 2026)

Incyte's (INCY) quarterly Enterprise Value came in at $18.2 billion in Q2 2026, up 68.98% on a YoY basis from $10.8 billion in Q2 2025, and up 23.26% quarter-over-quarter from $14.8 billion in Q1 2026.

Analysis

Incyte (INCY) Enterprise Value (2010 - 2026) Analysis & Trends

Incyte (INCY) has reported Enterprise Value for 17 consecutive years, with $18.2 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Enterprise Value rose 68.98% year-over-year to $18.2 billion; the trailing twelve-month figure through Jun 2026 stood at $18.2 billion (up 68.98% YoY), and the FY2025 full-year result was $16.0 billion, up 43.02% from the prior year.
  • Enterprise Value improved to $18.2 billion in Q2 2026 per INCY's latest filing, from $14.8 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at $18.2 billion in Q2 2026 and bottomed at $8.9 billion in Q1 2024.
  • Historically, Enterprise Value has averaged $12.4 billion across 5 years, with a median of $11.5 billion in 2022.
  • The sharpest annual moves came in 2024 and 2026: Enterprise Value plunged 31.27% in 2024, then surged 68.98% in 2026.
  • Over 5 years, Enterprise Value stood at $14.7 billion in 2022, then retreated by 28.84% to $10.4 billion in 2023, then rose by 7.44% to $11.2 billion in 2024, then soared by 43.02% to $16.0 billion in 2025, then rose by 13.89% to $18.2 billion in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered $18.2 billion, $14.8 billion, and $16.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
10 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.25 Bn
Mar 31, 2026 14.80 Bn
Dec 31, 2025 16.02 Bn
Sep 30, 2025 13.70 Bn
Jun 30, 2025 10.80 Bn
Mar 31, 2025 9.32 Bn
Dec 31, 2024 11.20 Bn
Sep 30, 2024 10.97 Bn
Jun 30, 2024 10.16 Bn
Mar 31, 2024 8.94 Bn
Dec 31, 2023 10.43 Bn
Sep 30, 2023 9.43 Bn
Jun 30, 2023 10.48 Bn
Mar 31, 2023 13.01 Bn
Dec 31, 2022 14.65 Bn
Sep 30, 2022 11.85 Bn
Jun 30, 2022 14.13 Bn
Mar 31, 2022 15.04 Bn
Dec 31, 2021 13.88 Bn
Sep 30, 2021 12.91 Bn